Public Hospitals Spend Over €4.25 Million on Cosmetic Procedures in 2024

Public hospitals have incurred expenses exceeding €4.25 million on cosmetic and plastic surgeries in 2024, marking an increase of nearly 17 percent from the previous year. The data, released by the Health Service Executive (HSE) under freedom of information laws, highlights the growing use of state-funded facilities for procedures traditionally associated with cosmetic enhancements.

A total of 744 patients underwent surgeries, including liposuction, facelifts, and breast augmentations, which is an increase of 79 surgeries compared to 2023. Notably, liposuction was performed on 85 individuals, costing approximately €831,864. According to the HSE, this procedure is characterized as one aimed at improving appearance rather than addressing health concerns.

Details on Procedures and Costs

In addition to liposuction, 37 patients received facelift and browlift surgeries, totaling €207,518. This figure is almost double the expenses from the previous year. Facelifts are designed to tighten sagging skin and reduce visible signs of aging, such as wrinkles and loose skin around the neck.

Breast augmentation procedures were also prevalent, with 57 surgeries conducted at a cost of €309,115. Another 70 patients underwent breast procedures involving application, removal, or insertion, costing €250,486. The most significant expenditure was associated with breast reduction surgeries, performed on 229 women, which amounted to nearly €2 million.

Other notable surgeries included ear repairs for 37 patients, costing €320,007, and rhinoplasty for another 37 individuals, costing €207,518. Eyelid excisions, performed on 119 people, totaled €208,078.

Funding and Justifications

The HSE has clarified that it is challenging to determine what portion of these costs is covered by taxpayers, private health insurers, or other funding sources. It emphasized that procedures funded by the HSE are considered plastic surgery rather than strictly cosmetic.

“Procedures paid for by the HSE for public patients relate to plastic, rather than ‘cosmetic’ surgery,” the HSE explained. “In the case of public patients, procedures of this nature are carried out only for clinical, and not cosmetic, reasons, and based on a clinical diagnosis by a medical consultant.” The HSE further noted that plastic surgery is intended to correct disfigurements or restore functionality due to accidents, congenital conditions, or medical treatments.

As the demand for these procedures continues to rise, the implications for healthcare funding and resource allocation remain significant. The increasing trend raises questions about the balance between medical necessity and cosmetic desires in public healthcare systems.